An analysis of extraskeletal osteosarcoma based on the literature

Abstract Extraskeletal osteosarcoma (ESOS) is a very rare malignant tumor. This study aimed to provide more evidence about the natural history and clinical features of ESOS, and clarify the impact of chemotherapy (CT) and radiotherapy (RT) on patient survival and postoperative recurrence for the sak...

Full description

Saved in:
Bibliographic Details
Main Authors: De-Hui Wang, Jun-Liang Zhang, Xiao-Wen Fan, Hui-Qun Du, Zi-Fan Gao, Dong-Dong Ling, Ying Cui, Meng-Han Chang, Xing Zhou
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-85197-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850098884715479040
author De-Hui Wang
Jun-Liang Zhang
Xiao-Wen Fan
Hui-Qun Du
Zi-Fan Gao
Dong-Dong Ling
Ying Cui
Meng-Han Chang
Xing Zhou
author_facet De-Hui Wang
Jun-Liang Zhang
Xiao-Wen Fan
Hui-Qun Du
Zi-Fan Gao
Dong-Dong Ling
Ying Cui
Meng-Han Chang
Xing Zhou
author_sort De-Hui Wang
collection DOAJ
description Abstract Extraskeletal osteosarcoma (ESOS) is a very rare malignant tumor. This study aimed to provide more evidence about the natural history and clinical features of ESOS, and clarify the impact of chemotherapy (CT) and radiotherapy (RT) on patient survival and postoperative recurrence for the sake of gaining a better understanding about the disease. Patient/tumor characteristics, recurrence, treatment, and follow-up durations were collected by searching studies in PubMed, Web of Science, Ovid, Elsevier, SpringerLink, Chinese National Knowledge Infrastructure (CNKI), and WAN FANG Data before June 30, 2023. Data were analyzed by SPSS-26. Altogether 1287 patients diagnosed with ESOS were retrieved from the literature. Of them, follow-up data were available in 981 patients, in whom 78 patients (7.6%) had metastases and 730 patients (74.5%) had localized disease at the time of diagnosis. Of the 730 patients with localized disease, 682 (93.4%) received surgical resection. The 5-year OS in all 981 patients, 78 metastatic patients, and 682 patients with localized disease was 33.40%, 4.9% and 41.1%, respectively. Of the 682 surgical patients, 367 patients underwent surgical resection alone, 170 received surgical resection + CT, 82 patients received surgical resection + RT, and 58 patients received both adjuvants. In addition, 348 (51%) of the 682 patients developed recurrence, including local recurrence (n = 102), metastasis (n = 130), and both (n = 116). Univariate analysis of 5-year PFS and 5-year OS showed that age, tumor size, CT, metastasis, and local recurrence were significant prognostic factors in the 682 patients with localized disease. There was no significant difference in 5-year OS between osteosarcoma-type and soft tissue-type regimens (P = 0.273). Multivariate analysis of 431 patients showed that postoperative recurrence and metastasis were significant prognostic factors for survival, and CT was not a significant prognostic factor, though CT decreased the incidence of local recurrence in ≤ 45-year age group (P = 0.047). RT reduced the incidence of local recurrence in patients ≤ 45years (P = 0.035) and patients with tumors > 5 cm (P = 0.044). So, we recommend that CT should be used for patients aged ≤ 45years, and RT can be used for patients ≤ 45years or those with tumors > 5 cm for the sake of decreasing the incidence of local recurrence, which we believe would indirectly benefit the survival of ESOS patients.
format Article
id doaj-art-47febfc17e2b4c87a77fcf647c0335bd
institution DOAJ
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-47febfc17e2b4c87a77fcf647c0335bd2025-08-20T02:40:36ZengNature PortfolioScientific Reports2045-23222025-01-0115111310.1038/s41598-025-85197-7An analysis of extraskeletal osteosarcoma based on the literatureDe-Hui Wang0Jun-Liang Zhang1Xiao-Wen Fan2Hui-Qun Du3Zi-Fan Gao4Dong-Dong Ling5Ying Cui6Meng-Han Chang7Xing Zhou8Department of Orthopedics, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing UniversityDepartment of Orthopedics, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing UniversityJinling Clinical Medical College, Nanjing University of Chinese MedicineDepartment of Orthopedics, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing UniversityJinling Clinical Medical College, Nanjing University of Chinese MedicineDepartment of Orthopedics, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing UniversityDepartment of Orthopedics, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing UniversityDepartment of Orthopedics, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing UniversityDepartment of Orthopedics, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing UniversityAbstract Extraskeletal osteosarcoma (ESOS) is a very rare malignant tumor. This study aimed to provide more evidence about the natural history and clinical features of ESOS, and clarify the impact of chemotherapy (CT) and radiotherapy (RT) on patient survival and postoperative recurrence for the sake of gaining a better understanding about the disease. Patient/tumor characteristics, recurrence, treatment, and follow-up durations were collected by searching studies in PubMed, Web of Science, Ovid, Elsevier, SpringerLink, Chinese National Knowledge Infrastructure (CNKI), and WAN FANG Data before June 30, 2023. Data were analyzed by SPSS-26. Altogether 1287 patients diagnosed with ESOS were retrieved from the literature. Of them, follow-up data were available in 981 patients, in whom 78 patients (7.6%) had metastases and 730 patients (74.5%) had localized disease at the time of diagnosis. Of the 730 patients with localized disease, 682 (93.4%) received surgical resection. The 5-year OS in all 981 patients, 78 metastatic patients, and 682 patients with localized disease was 33.40%, 4.9% and 41.1%, respectively. Of the 682 surgical patients, 367 patients underwent surgical resection alone, 170 received surgical resection + CT, 82 patients received surgical resection + RT, and 58 patients received both adjuvants. In addition, 348 (51%) of the 682 patients developed recurrence, including local recurrence (n = 102), metastasis (n = 130), and both (n = 116). Univariate analysis of 5-year PFS and 5-year OS showed that age, tumor size, CT, metastasis, and local recurrence were significant prognostic factors in the 682 patients with localized disease. There was no significant difference in 5-year OS between osteosarcoma-type and soft tissue-type regimens (P = 0.273). Multivariate analysis of 431 patients showed that postoperative recurrence and metastasis were significant prognostic factors for survival, and CT was not a significant prognostic factor, though CT decreased the incidence of local recurrence in ≤ 45-year age group (P = 0.047). RT reduced the incidence of local recurrence in patients ≤ 45years (P = 0.035) and patients with tumors > 5 cm (P = 0.044). So, we recommend that CT should be used for patients aged ≤ 45years, and RT can be used for patients ≤ 45years or those with tumors > 5 cm for the sake of decreasing the incidence of local recurrence, which we believe would indirectly benefit the survival of ESOS patients.https://doi.org/10.1038/s41598-025-85197-7Extraskeletal osteosarcomaChemotherapyRadiotherapy
spellingShingle De-Hui Wang
Jun-Liang Zhang
Xiao-Wen Fan
Hui-Qun Du
Zi-Fan Gao
Dong-Dong Ling
Ying Cui
Meng-Han Chang
Xing Zhou
An analysis of extraskeletal osteosarcoma based on the literature
Scientific Reports
Extraskeletal osteosarcoma
Chemotherapy
Radiotherapy
title An analysis of extraskeletal osteosarcoma based on the literature
title_full An analysis of extraskeletal osteosarcoma based on the literature
title_fullStr An analysis of extraskeletal osteosarcoma based on the literature
title_full_unstemmed An analysis of extraskeletal osteosarcoma based on the literature
title_short An analysis of extraskeletal osteosarcoma based on the literature
title_sort analysis of extraskeletal osteosarcoma based on the literature
topic Extraskeletal osteosarcoma
Chemotherapy
Radiotherapy
url https://doi.org/10.1038/s41598-025-85197-7
work_keys_str_mv AT dehuiwang ananalysisofextraskeletalosteosarcomabasedontheliterature
AT junliangzhang ananalysisofextraskeletalosteosarcomabasedontheliterature
AT xiaowenfan ananalysisofextraskeletalosteosarcomabasedontheliterature
AT huiqundu ananalysisofextraskeletalosteosarcomabasedontheliterature
AT zifangao ananalysisofextraskeletalosteosarcomabasedontheliterature
AT dongdongling ananalysisofextraskeletalosteosarcomabasedontheliterature
AT yingcui ananalysisofextraskeletalosteosarcomabasedontheliterature
AT menghanchang ananalysisofextraskeletalosteosarcomabasedontheliterature
AT xingzhou ananalysisofextraskeletalosteosarcomabasedontheliterature
AT dehuiwang analysisofextraskeletalosteosarcomabasedontheliterature
AT junliangzhang analysisofextraskeletalosteosarcomabasedontheliterature
AT xiaowenfan analysisofextraskeletalosteosarcomabasedontheliterature
AT huiqundu analysisofextraskeletalosteosarcomabasedontheliterature
AT zifangao analysisofextraskeletalosteosarcomabasedontheliterature
AT dongdongling analysisofextraskeletalosteosarcomabasedontheliterature
AT yingcui analysisofextraskeletalosteosarcomabasedontheliterature
AT menghanchang analysisofextraskeletalosteosarcomabasedontheliterature
AT xingzhou analysisofextraskeletalosteosarcomabasedontheliterature